Related Experiment Video
Updated: May 11, 2026
06:21
Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
Analysis of finite dose dermal absorption data: implications for dermal exposure assessment
H Frederick Frasch1, G Scott Dotson2, Annette L Bunge3
1Health Effects Laboratory, National Institute for Occupational Safety and Health, Morgantown, WV, USA.
Summary
This study introduces new algebraic tools to better evaluate dermal absorption experiments. These methods offer a more data-driven approach to assessing chemical uptake through the skin.
Area of Science:
- Environmental Health
- Toxicology
- Dermal Exposure Assessment
Background:
- The fixed fractional absorption approach is commonly used to estimate chemical uptake via skin contact.
- This method assumes a constant absorption fraction, but lacks clear experimental evaluation guidelines.
Purpose of the Study:
- To analyze experiments measuring fractional dermal absorption.
- To discuss limitations of the fixed fractional absorption approach.
- To provide tools for a more data-driven dermal exposure assessment.
Main Methods:
- Analysis of experimental data for fractional dermal absorption.
- Development of simple algebraic expressions for evaluating finite dose dermal absorption experiments.
Main Results:
- Established a framework for evaluating dermal absorption experiments.
- Identified limitations of the fixed fractional absorption approach.
- Demonstrated application through case studies.
Conclusions:
- The proposed algebraic tools enhance the evaluation of dermal absorption data.
- A more data-driven approach to dermal exposure assessment is facilitated.
- Improved understanding of chemical uptake through the skin is achieved.
More Related Videos
Related Concept Videos
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:30Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...